Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
Clinical and Translational Gastroenterology|May 26, 2022
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational StudyYuki Kasai, Takaomi Kessoku, Kosuke Tanaka, et al.
Gastro Hep Advances|August 12, 2024
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLDHidenori Toyoda, Hideki Fujii, Michihiro Iwaki, et al.
Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.
Gastro Hep Advances|June 11, 2025
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7SHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Journal of Gastroenterology and Hepatology|October 5, 2022
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in AsiaYuya Seko, Miwa Kawanaka, Hideki Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 27, 2023
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver diseaseHideki Fujii, Makoto Fujii, Michihiro Iwaki, et al.
BMJ Open|November 24, 2024
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocolMichihiro Iwaki, Takashi Kobayashi, Asako Nogami, et al.
Journal of Gastroenterology and Hepatology|August 19, 2023
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learningTakanori Ito, Hikaru Morooka, Hirokazu Takahashi, et al.
Pageof 9